E-Pub Articles Ahead of Print ::: Current Drug Safety

ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)


Volume 12, 3 Issues, 2017


Download PDF Flyer




Current Drug Safety

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Dr. Seetal Dodd
University of Melbourne
Geelong, 3220
Australia


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Articles Ahead of Print

Metronidazole and Norfloxacin Induced Generalized Fixed Drug Eruptions in an Adult male Patient – A Case Report


Nidhi S. Patel, Bhavesh C. Chavada, Viren N. Naik, Hiteshkumar N. Patel and C B Tripathi.


View Abstract View on PubMed


A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital


Khyati Doshi, Radha Yegnanarayan and Neeta Gokhale.


View Abstract View on PubMed


A Case Report of Antitubercular Drugs Induced Exanthematous Reaction Complicated by Acute Onset Levofloxacin Induced Toxic Epidermal Necrolysis (TEN)


Khushboo Gajjar, Hiren Hirapara, Chandra S. Jaiswal, Manish Barvaliya, Hita Shah and CB Tripathi.


View Abstract View on PubMed


Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?


Piero Vasapollo, Erika Cione, Filippo Luciani and Luca Gallelli.


View Abstract View on PubMed


Biological Therapy in Inflammatory Bowel Diseases: Safety Profile


Antonio Di Sario, Emanuele Bendia, Laura Schiadà, Paola Sassaroli and Antonio Benedetti.


View Abstract View on PubMed


Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals




Related eBooks



Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science